Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, NRC Health reported revenue of $137M, down 4.0% year over year. Operating margin was 16.4% and net margin 8.4%, on a free-cash-flow margin of 11.5% with capital expenditure at 7.8% of revenue. Every figure is computed directly from NRC's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $137M | 16.4% | 8.4% |
| FY2024 | $143M | 24.6% | 17.3% |
| FY2023 | $149M | 27.0% | 20.8% |
| FY2022 | $152M | 30.7% | 21.0% |
| FY2021 | $148M | 34.0% | 25.3% |
How does NRC compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 23 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: IQV · ACM · BAH · ICLR · PAYX · IT
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.